Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line
- PMID: 1899107
- PMCID: PMC2118792
- DOI: 10.1084/jem.173.2.519
Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line
Abstract
To test the transforming potential of deregulated P40/Interleukin 9 expression, we transfected a mouse P40-dependent T cell line with P40 cDNA, and examined the tumorigenicity of the resulting transfectants. When the cells, which grew autonomously in vitro, were injected intraperitoneally or subcutaneously into syngeneic mice, a very high tumor incidence was observed with as few as 10(4) cells per inoculum. Animals died as a result of widespread dissemination of lymphomatous tissue to abdominal and thoracic organs. The same P40-dependent cell line transfected with a control construct did not form tumors even after injection of 10(7) cells. These results indicate that uncontrolled expression of P40 can support T cell proliferation in vivo, and may be a transforming event involved in the development of certain T cell tumors.
Similar articles
-
Functional and biochemical characterization of mouse P40/IL-9 receptors.J Immunol. 1990 Oct 15;145(8):2494-9. J Immunol. 1990. PMID: 2145361
-
Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene.J Immunol. 1990 Jun 1;144(11):4235-41. J Immunol. 1990. PMID: 1971295
-
Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.J Immunol. 1991 May 1;146(9):3074-81. J Immunol. 1991. PMID: 1673147
-
Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).Eur J Immunol. 1990 Jun;20(6):1413-6. doi: 10.1002/eji.1830200632. Eur J Immunol. 1990. PMID: 2115002
-
[Function, molecular structure and gene expression regulation of interleukin 9 (IL-9)].Nihon Rinsho. 1992 Aug;50(8):1821-6. Nihon Rinsho. 1992. PMID: 1433974 Review. Japanese.
Cited by
-
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.Blood. 2006 Oct 1;108(7):2407-15. doi: 10.1182/blood-2006-04-020305. Epub 2006 Jun 8. Blood. 2006. PMID: 16763206 Free PMC article.
-
Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris.Infect Immun. 1998 Aug;66(8):3832-40. doi: 10.1128/IAI.66.8.3832-3840.1998. Infect Immun. 1998. PMID: 9673269 Free PMC article.
-
MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity.Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13555-60. doi: 10.1073/pnas.95.23.13555. Proc Natl Acad Sci U S A. 1998. PMID: 9811838 Free PMC article.
-
Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF.Ann Hematol. 1993 Jan;66(1):45-9. doi: 10.1007/BF01737688. Ann Hematol. 1993. PMID: 8431521
-
Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells.Immunity. 2012 Apr 20;36(4):623-34. doi: 10.1016/j.immuni.2012.01.020. Epub 2012 Apr 12. Immunity. 2012. PMID: 22503540 Free PMC article.